Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Craig

Showing results (261-270 of 321) with videos related to

Pageof 33
Sort By:
Archives of Pathology & Laboratory Medicine|June 15, 2017
Molecular and Immune Biomarkers in Acute Respiratory Distress Syndrome: A Perspective From Members of the Pulmonary Pathology SocietyVera Luiza Capelozzi, Timothy Craig Allen, Mary Beth Beasley, et al.
Journal of Personalized Medicine|December 23, 2022
Personalized Medicine and Obstructive Sleep ApneaSy Duong-Quy, Hoang Nguyen-Huu, Dinh Hoang-Chau-Bao, et al.
Archives of Pathology & Laboratory Medicine|January 19, 2016
Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology SocietyLynette M Sholl, Dara L Aisner, Timothy Craig Allen, et al.
The Journal of Allergy and Clinical Immunology|April 19, 2025
Impact of climate change on aerobiology, rhinitis, and allergen immunotherapy: Work Group Report from the Aerobiology, Rhinitis, Rhinosinusitis & Ocular Allergy, and Immunotherapy, Allergen Standardization & Allergy Diagnostics Committees of the American Academy of Allergy, Asthma & ImmunologyTolly E G Epstein, Andrew C Rorie, German D Ramon, et al.
Archives of Pathology & Laboratory Medicine|May 20, 2016
Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology SocietyLynette M Sholl, Dara L Aisner, Timothy Craig Allen, et al.
Orphanet Journal of Rare Diseases|July 29, 2021
Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension studyWilliam R Lumry, Bruce Zuraw, Marco Cicardi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 20, 2023
Once-Daily Oral Berotralstat for Long-Term Prophylaxis of Hereditary Angioedema: The Open-Label Extension of the APeX-2 Randomized TrialSorena Kiani-Alikhan, Richard Gower, Timothy Craig, et al.
Orphanet Journal of Rare Diseases|February 16, 2021
Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension studyWilliam R Lumry, Bruce Zuraw, Marco Cicardi, et al.
Advances in Therapy|June 12, 2025
Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World StudyJonathan A Bernstein, Stephen D Betschel, Paula J Busse, et al.
BMJ Global Health|November 10, 2025
Variation in global trauma care: a survey of 187 hospitals across 51 countriesThomas Edmiston, Michael F Bath, Eder Caceres, et al.
Pageof 33

Showing results (261-270 of 321) with videos related to

Sort By:
Pageof 33
Archives of Pathology & Laboratory Medicine|June 15, 2017
Molecular and Immune Biomarkers in Acute Respiratory Distress Syndrome: A Perspective From Members of the Pulmonary Pathology SocietyVera Luiza Capelozzi, Timothy Craig Allen, Mary Beth Beasley, et al.
Journal of Personalized Medicine|December 23, 2022
Personalized Medicine and Obstructive Sleep ApneaSy Duong-Quy, Hoang Nguyen-Huu, Dinh Hoang-Chau-Bao, et al.
Archives of Pathology & Laboratory Medicine|January 19, 2016
Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology SocietyLynette M Sholl, Dara L Aisner, Timothy Craig Allen, et al.
The Journal of Allergy and Clinical Immunology|April 19, 2025
Impact of climate change on aerobiology, rhinitis, and allergen immunotherapy: Work Group Report from the Aerobiology, Rhinitis, Rhinosinusitis & Ocular Allergy, and Immunotherapy, Allergen Standardization & Allergy Diagnostics Committees of the American Academy of Allergy, Asthma & ImmunologyTolly E G Epstein, Andrew C Rorie, German D Ramon, et al.
Archives of Pathology & Laboratory Medicine|May 20, 2016
Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology SocietyLynette M Sholl, Dara L Aisner, Timothy Craig Allen, et al.
Orphanet Journal of Rare Diseases|July 29, 2021
Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension studyWilliam R Lumry, Bruce Zuraw, Marco Cicardi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 20, 2023
Once-Daily Oral Berotralstat for Long-Term Prophylaxis of Hereditary Angioedema: The Open-Label Extension of the APeX-2 Randomized TrialSorena Kiani-Alikhan, Richard Gower, Timothy Craig, et al.
Orphanet Journal of Rare Diseases|February 16, 2021
Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension studyWilliam R Lumry, Bruce Zuraw, Marco Cicardi, et al.
Advances in Therapy|June 12, 2025
Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World StudyJonathan A Bernstein, Stephen D Betschel, Paula J Busse, et al.
BMJ Global Health|November 10, 2025
Variation in global trauma care: a survey of 187 hospitals across 51 countriesThomas Edmiston, Michael F Bath, Eder Caceres, et al.
Pageof 33